PGE

Jansen, C. S. et al. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature 576, 465–470 (2019).

pubmed: 31827286 pmcid: 7108171 doi: 10.1038/s41586-019-1836-5

Siddiqui, I. et al. Intratumoral Tcf1

pubmed: 30635237 doi: 10.1016/j.immuni.2018.12.021

Prokhnevska, N. et al. CD8

pubmed: 36580918 doi: 10.1016/j.immuni.2022.12.002

Zehn, D., Thimme, R., Lugli, E., de Almeida, G. P. & Oxenius, A. ‘Stem-like’ precursors are the fount to sustain persistent CD8

pubmed: 35624209 doi: 10.1038/s41590-022-01219-w

Miller, B. C. et al. Subsets of exhausted CD8

pubmed: 30778252 pmcid: 6673650 doi: 10.1038/s41590-019-0312-6

Codarri Deak, L. et al. PD-1-cis IL-2R agonism yields better effectors from stem-like CD8

pubmed: 36171284 pmcid: 9534752 doi: 10.1038/s41586-022-05192-0

Krishna, S. et al. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science 370, 1328–1334 (2020).

pubmed: 33303615 pmcid: 8883579 doi: 10.1126/science.abb9847

Liu, B. et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat. Cancer 3, 108–121 (2022).

pubmed: 35121991 doi: 10.1038/s43018-021-00292-8

Kurtulus, S. et al. Checkpoint blockade immunotherapy induces dynamic changes in PD-1–CD8

pubmed: 30635236 pmcid: 6336113 doi: 10.1016/j.immuni.2018.11.014

Gatto, F., Schulze, A. & Nielsen, J. Systematic analysis reveals that cancer mutations converge on deregulated metabolism of arachidonate and xenobiotics. Cell Rep. 16, 878–895 (2016).

pubmed: 27396332 doi: 10.1016/j.celrep.2016.06.038

Wang, D. & DuBois, R. N. Eicosanoids and cancer. Nat. Rev. Cancer 10, 181–193 (2010).

pubmed: 20168319 pmcid: 2898136 doi: 10.1038/nrc2809

Wang, Q., Morris, R. J., Bode, A. M. & Zhang, T. Prostaglandin pathways: opportunities for cancer prevention and therapy. Cancer Res. 82, 949–965 (2022).

pubmed: 34949672 pmcid: 8930508 doi: 10.1158/0008-5472.CAN-21-2297

Finetti, F. et al. Prostaglandin E2 and cancer: insight into tumor progression and immunity. Biology 9, 434 (2020).

pubmed: 33271839 pmcid: 7760298 doi: 10.3390/biology9120434

Zelenay, S. et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162, 1257–1270 (2015).

pubmed: 26343581 pmcid: 4597191 doi: 10.1016/j.cell.2015.08.015

Böttcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022–1037.e14 (2018).

pubmed: 29429633 pmcid: 5847168 doi: 10.1016/j.cell.2018.01.004

Kalinski, P. Regulation of immune responses by prostaglandin E2. J. Immunol. 188, 21–28 (2012).

pubmed: 22187483 doi: 10.4049/jimmunol.1101029

Chen, J. H. et al. Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection. Nat. Med. 21, 327–334 (2015).

pubmed: 25799228 pmcid: 4505619 doi: 10.1038/nm.3831

Mosenden, R. et al. Mice with disrupted type I protein kinase A anchoring in T cells resist retrovirus-induced immunodeficiency. J. Immunol. 186, 5119–5130 (2011).

pubmed: 21430226 doi: 10.4049/jimmunol.1100003

Newick, K. et al. Augmentation of CAR T-cell trafficking and antitumor efficacy by blocking protein kinase A localization. Cancer Immunol. Res. 4, 541–551 (2015).

doi: 10.1158/2326-6066.CIR-15-0263

Lone, A. M. & Taskén, K. Phosphoproteomics-based characterization of prostaglandin E2 signaling in T cells. Mol. Pharmacol. 99, 370–382 (2021).

pubmed: 33674363 doi: 10.1124/molpharm.120.000170

Roberts, E. W. et al. Critical role for CD103

pubmed: 27424807 pmcid: 5374862 doi: 10.1016/j.ccell.2016.06.003

Spranger, S., Bao, R. & Gajewski, T. F. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. Nature 523, 231–235 (2015).

pubmed: 25970248 doi: 10.1038/nature14404

Böttcher, J. P. et al. Functional classification of memory CD8

pubmed: 26404698 doi: 10.1038/ncomms9306

Zander, R. et al. CD4

pubmed: 31810883 pmcid: 6929322 doi: 10.1016/j.immuni.2019.10.009

Aandahl, E. M. et al. CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets. J. Immunol. 170, 2349–2355 (2003).

pubmed: 12594257 doi: 10.4049/jimmunol.170.5.2349

Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265–269 (2019).

pubmed: 31207605 doi: 10.1038/s41586-019-1326-9

Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270–274 (2019).

pubmed: 31207604 pmcid: 7698992 doi: 10.1038/s41586-019-1324-y

Tsui, C. et al. MYB orchestrates T cell exhaustion and response to checkpoint inhibition. Nature 609, 354–360 (2022).

pubmed: 35978192 pmcid: 9452299 doi: 10.1038/s41586-022-05105-1

Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251–1259 (2019).

pubmed: 31359002 pmcid: 6689255 doi: 10.1038/s41591-019-0522-3

Lucca, L. E. et al. Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells. J. Exp. Med. 218, e20200921 (2021).

pubmed: 33651881 pmcid: 7933991 doi: 10.1084/jem.20200921

Mandala, S. et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346–349 (2002).

pubmed: 11923495 doi: 10.1126/science.1070238

Ross, S. H. & Cantrell, D. A. Signaling and function of interleukin-2 in T lymphocytes. Annu. Rev. Immunol. 36, 411–433 (2018).

pubmed: 29677473 pmcid: 6472684 doi: 10.1146/annurev-immunol-042617-053352

Hashimoto, M. et al. PD-1 combination therapy with IL-2 modifies CD8

pubmed: 36171288 pmcid: 9793890 doi: 10.1038/s41586-022-05257-0

Corria-Osorio, J. et al. Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8

pubmed: 37081150 pmcid: 10154250 doi: 10.1038/s41590-023-01477-2

Di Pilato, M. et al. CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. Cell 184, 4512–4530.e22 (2021).

pubmed: 34343496 pmcid: 8719451 doi: 10.1016/j.cell.2021.07.015

Danilo, M., Chennupati, V., Silva, J. G., Siegert, S. & Held, W. Suppression of Tcf1 by inflammatory cytokines facilitates effector CD8 T cell differentiation. Cell Rep. 22, 2107–2117 (2018).

pubmed: 29466737 doi: 10.1016/j.celrep.2018.01.072

Morotti, M. et al. PGE

Bayerl, F. et al. Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses. Immunity 56, 1341–1358.e11 (2023).

pubmed: 37315536 doi: 10.1016/j.immuni.2023.05.011

Meiser, P. et al. A distinct stimulatory cDC1 subpopulation amplifies CD8

pubmed: 37451271 doi: 10.1016/j.ccell.2023.06.008

Mo, F. et al. An engineered IL-2 partial agonist promotes CD8

pubmed: 34526724 pmcid: 9172917 doi: 10.1038/s41586-021-03861-0

Tichet, M. et al. Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8

pubmed: 36630914 doi: 10.1016/j.immuni.2022.12.006

Leonard, W. J., Lin, J.-X. & O’Shea, J. J. The γc family of cytokines: basic biology to therapeutic ramifications. Immunity 50, 832–850 (2019).

pubmed: 30995502 doi: 10.1016/j.immuni.2019.03.028

Biringer, R. G. A review of prostanoid receptors: expression, characterization, regulation, and mechanism of action. J. Cell Commun. Signal. 15, 155–184 (2021).

pubmed: 32970276 doi: 10.1007/s12079-020-00585-0

Wübbenhorst, D. et al. Tetracycline-regulated bone morphogenetic protein 2 gene expression in lentivirally transduced primary rabbit chondrocytes for treatment of cartilage defects. Arthritis Rheum. 62, 2037–2046 (2010).

pubmed: 20309869 doi: 10.1002/art.27461

Di Pilato, M. et al. Targeting the CBM complex causes T

pubmed: 31092922 pmcid: 6656391 doi: 10.1038/s41586-019-1215-2

Oh, S. A., Seki, A. & Rutz, S. Ribonucleoprotein transfection for CRISPR/Cas9-mediated gene knockout in primary T cells. Curr. Protoc. Immunol. 124, e69 (2019).

pubmed: 30334617 doi: 10.1002/cpim.69

Labun, K. et al. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 47, W171–W174 (2019).

pubmed: 31106371 pmcid: 6602426 doi: 10.1093/nar/gkz365

Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR–Cas9. Nat. Biotechnol. 34, 184–191 (2016).

pubmed: 26780180 pmcid: 4744125 doi: 10.1038/nbt.3437

Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).

pubmed: 28091601 pmcid: 5241818 doi: 10.1038/ncomms14049

Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021).

pubmed: 34062119 pmcid: 8238499 doi: 10.1016/j.cell.2021.04.048

Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).

pubmed: 31870423 pmcid: 6927181 doi: 10.1186/s13059-019-1874-1

Ahlmann-Eltze, C. & Huber, W. glmGamPoi: fitting Gamma–Poisson generalized linear models on single cell count data. Bioinformatics 36, 5701–5702 (2021).

pubmed: 33295604 doi: 10.1093/bioinformatics/btaa1009

Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163–172 (2019).

pubmed: 30643263 pmcid: 6340744 doi: 10.1038/s41590-018-0276-y

Gattinoni, L. et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 17, 1290–1297 (2011).

pubmed: 21926977 pmcid: 3192229 doi: 10.1038/nm.2446

Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).

pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8

Kaech, S. M., Hemby, S., Kersh, E. & Ahmed, R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111, 837–851 (2002).

pubmed: 12526810 doi: 10.1016/S0092-8674(02)01139-X

Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).

pubmed: 29914354 pmcid: 6007078 doi: 10.1186/s12864-018-4772-0

Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Research 9, 47 (2020).

pubmed: 32789006 pmcid: 7400693 doi: 10.12688/f1000research.22139.1

Badia-I-Mompel, P. et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform. Adv. 2, vbac016 (2022).

pubmed: 36699385 pmcid: 9710656 doi: 10.1093/bioadv/vbac016

Holland, C. H., Szalai, B. & Saez-Rodriguez, J. Transfer of regulatory knowledge from human to mouse for functional genomics analysis. Biochim. Biophys. Acta Gene Regul. Mech. 1863, 194431 (2020).

pubmed: 31525460 doi: 10.1016/j.bbagrm.2019.194431

Pedersen, T. tidygraph: A tidy API for graph manipulation. GitHub https://github.com/thomasp85/tidygraph (2023).

Csárdi, G. and Nepusz, T. The igraph software package for complex network research. Gigascience https://doi.org/10.1093/gigascience/giab008 (2006).

Ramírez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160–W165 (2016).

pubmed: 27079975 pmcid: 4987876 doi: 10.1093/nar/gkw257

Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, giab008 (2021).

pubmed: 33590861 pmcid: 7931819 doi: 10.1093/gigascience/giab008

Ou, J. & Zhu, L. J. trackViewer: a Bioconductor package for interactive and integrative visualization of multi-omics data. Nat. Methods 16, 453–454 (2019).

pubmed: 31133757 doi: 10.1038/s41592-019-0430-y

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Classifications MeSH